FEBRUARY 9th, 2024
Aptar has entered into an enterprise agreement with Biogen Inc. to operate and develop digital health solutions for neurological and rare diseases.
Biogen will transfer ownership of select digital health solutions to Aptar Digital Health and we will provide a full range of capabilities including the product management, design, development and maintenance of software applications, secured cloud hosting and customer and marketing support.
The initial scope of multi-year agreement covers several indications in neurology and immunology across 15 countries.
You can read the press release below to learn more.
